Australia has established a range of innovation funding incentives designed to foster research, development, and commercialisation across various sectors. These initiatives, primarily driven by the Australian Government, aim to stimulate business investment in R&D, encourage entrepreneurship, and enhance the nation’s global competitiveness. This report will detail the key funding mechanisms available, their objectives, and their impact on fostering a vibrant innovation ecosystem in Australia.
The R&D Tax Incentive (R&DTI) is the cornerstone of Australia’s innovation funding landscape, encouraging businesses to undertake R&D activities they might otherwise not pursue due to financial risk. It is jointly administered by the Department of Industry, Science and Resources (DISR) and the Australian Tax Office (ATO)
Mechanism (Turnover < AUD$20 million): For companies with an aggregated turnover of less than AUD$20 million, a refundable tax offset is available, calculated as the company’s corporate tax rate plus an 18.5 percentage point premium. This means the total refundable offset rate typically ranges from 43.5% to 48.5% of eligible R&D expenditure (for R&D conducted from 1 July 2021). The balance is paid as a cash refund if the offset exceeds the company’s tax liability.
Mechanism (Turnover ≥ AUD$20 million): For larger entities (turnover of AUD$20 million or more), a non-refundable tax offset is provided, calculated at the company’s tax rate plus an incremental premium based on R&D intensity:
→ Low Intensity (up to 2% R&D intensity): 8.5% premium above the corporate tax rate.
→ High Intensity (above 2% R&D intensity): 16.5% premium above the corporate tax rate.
Eligibility: To qualify, activities must be systematic, experimental, and aimed at generating new knowledge or solving technical challenges. Eligible expenses include salaries for technical staff, prototype development, software used in experiments, and direct research materials
Impact:The R&DTI helps reduce the financial strain of innovation, allowing companies to invest further in technology development and product improvement. It benefits a wide range of industries, with a significant share going to manufacturing, scientific/technical services, and IT. In the 2022 financial year, it facilitated around $3 billion in benefits
The Industry Growth Program provides advice and grant funding specifically for innovative small to medium enterprises (SMEs) and startups. It focuses on helping businesses commercialise their ideas and grow, particularly those aligning with the National Reconstruction Fund (NRF) priority areas
→ Early-Stage Commercialisation Grants: $50,000 to $250,000 for projects at Technology Readiness Levels (TRLs) 3 to 6.
→ Commercialisation and Growth Grants: $100,000 to $5 million for projects at TRLs 4 to 9 (prototyping through to market readiness and scaling).
Focus Areas: Projects must align with the NRF priority areas, which include value-add in resources and agriculture, transport, medical science, renewables/low emissions technologies, defence capability, and enabling capabilities.
Eligibility: Companies must typically have a combined annual turnover of less than AUD$20 million for the three preceding financial years and must have received an Advisory Service report before applying for a grant.
Impact: This programme supports scaling innovative products and accelerates growth into national and international markets.
To stimulate investment in early-stage innovation companies (ESICs), Australia offers tax incentives to eligible investors.
Mechanism: Investors in qualifying ESICs can receive two key benefits:
→ Tax Offset: A 20% non-refundable tax offset on the amount invested, capped at AUD$200,000 per investor per year (for investments up to $1 million).
→ Capital Gains Tax (CGT) Exemption: A 10-year exemption on capital gains for investments held as shares in an ESIC for at least 12 months (up to 10 years). Any losses realised on the investment are generally disregarded.
Eligibility (Company): To qualify as an ESIC, the company must be unlisted, incorporated within the last three to six years, and pass the Early Stage Test ($1 million or less in expenses and $200,000 or less in assessable income) and one of the two Innovation Tests (the 100-Point Test or the Principles-Based Test).
Impact: This incentive helps bridge the funding gap for nascent businesses, encouraging venture capital and angel investment in the crucial early stages of development
Various other grants exist at both federal and state levels, often targeting specific industries or regional development:
These incentives collectively foster a dynamic innovation ecosystem. The R&DTI significantly lowers the cost of R&D, while direct grants and ESIC incentives address critical funding gaps for startups and SMEs. The focus on priority areas through programs like the IGP aligns innovation with national economic strategies.
While the Australian venture capital landscape saw a funding recovery in 2024, particularly in early-stage investment, challenges persist in later-stage funding . Continued government support through these diverse incentives, coupled with efforts to strengthen university-industry collaboration and regulatory support, will be crucial for Australia to build a more resilient and globally competitive innovation economy.